157 related articles for article (PubMed ID: 1431886)
1. The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria.
Hershko C; Gordeuk VR; Thuma PE; Theanacho EN; Spira DT; Hider RC; Peto TE; Brittenham GM
J Inorg Biochem; 1992 Aug 15-Sep; 47(3-4):267-77. PubMed ID: 1431886
[TBL] [Abstract][Full Text] [Related]
2. The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators.
Hershko C; Theanacho EN; Spira DT; Peter HH; Dobbin P; Hider RC
Blood; 1991 Feb; 77(3):637-43. PubMed ID: 1991172
[TBL] [Abstract][Full Text] [Related]
3. Iron chelating agents for treating malaria.
Smith HJ; Meremikwu M
Cochrane Database Syst Rev; 2003; (2):CD001474. PubMed ID: 12804409
[TBL] [Abstract][Full Text] [Related]
4. Antimalarial effect of iron chelators.
Gordeuk VR; Loyevsky M
Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
[No Abstract] [Full Text] [Related]
5. Antimalarial iron chelator, FBS0701, shows asexual and gametocyte Plasmodium falciparum activity and single oral dose cure in a murine malaria model.
Ferrer P; Tripathi AK; Clark MA; Hand CC; Rienhoff HY; Sullivan DJ
PLoS One; 2012; 7(5):e37171. PubMed ID: 22629364
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.
Pattanapanyasat K; Thaithong S; Kyle DE; Udomsangpetch R; Yongvanitchit K; Hider RC; Webster HK
Cytometry; 1997 Jan; 27(1):84-91. PubMed ID: 9000589
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans.
Thuma PE; Olivieri NF; Mabeza GF; Biemba G; Parry D; Zulu S; Fassos FF; McClelland RA; Koren G; Brittenham GM; Gordeuk VR
Am J Trop Med Hyg; 1998 Mar; 58(3):358-64. PubMed ID: 9546419
[TBL] [Abstract][Full Text] [Related]
8. Clinical studies of iron chelators in malaria.
Mabeza GF; Biemba G; Gordeuk VR
Acta Haematol; 1996; 95(1):78-86. PubMed ID: 8604591
[TBL] [Abstract][Full Text] [Related]
9. [Iron chelation in antimalarial therapy].
Pradines B; Millet J; Henry M
Med Trop (Mars); 2003; 63(2):119-30. PubMed ID: 12910648
[TBL] [Abstract][Full Text] [Related]
10. Antimalarial properties of orally active iron chelators.
Heppner DG; Hallaway PE; Kontoghiorghes GJ; Eaton JW
Blood; 1988 Jul; 72(1):358-61. PubMed ID: 3291984
[TBL] [Abstract][Full Text] [Related]
11. Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum.
Pattanapanyasat K; Kotipun K; Yongvanitchit K; Hider RC; Kyle DE; Heppner DG; Walsh DS
Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):64-9. PubMed ID: 11485097
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial effect of HBED and other phenolic and catecholic iron chelators.
Yinnon AM; Theanacho EN; Grady RW; Spira DT; Hershko C
Blood; 1989 Nov; 74(6):2166-71. PubMed ID: 2508794
[TBL] [Abstract][Full Text] [Related]
13. Malaria and iron: history and review.
Weinberg ED; Moon J
Drug Metab Rev; 2009; 41(4):644-62. PubMed ID: 19764831
[TBL] [Abstract][Full Text] [Related]
14. Control of disease by selective iron depletion: a novel therapeutic strategy utilizing iron chelators.
Hershko C
Baillieres Clin Haematol; 1994 Dec; 7(4):965-1000. PubMed ID: 7881162
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimalarial activity of amide and ester conjugates of siderophores and ozonides.
Tiwari R; Checkley L; Ferdig MT; Vennerstrom JL; Miller MJ
Biometals; 2023 Apr; 36(2):315-320. PubMed ID: 35229216
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects on bovine babesial infection by iron chelator, 1-(N-acetyl-6-aminohexyl)- 3-hydroxy-2-methylpyridin-4-one (CM1), and antimalarial drugs.
Koonyosying P; Srichairatanakool S; Tiwananthagorn S; Sthitmatee N
Vet Parasitol; 2023 Dec; 324():110055. PubMed ID: 37931475
[TBL] [Abstract][Full Text] [Related]
17. Iron chelators as anti-infectives; malaria as a paradigm.
Cabantchik ZI; Moody-Haupt S; Gordeuk VR
FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):289-98. PubMed ID: 10575141
[TBL] [Abstract][Full Text] [Related]
18. Control of malaria by drug-mediated iron deprivation.
Hershko C; Cabantchik ZI
Isr J Med Sci; 1994 Nov; 30(11):840-5. PubMed ID: 7982777
[No Abstract] [Full Text] [Related]
19. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
[TBL] [Abstract][Full Text] [Related]
20. Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.
Bueno JM; Herreros E; Angulo-Barturen I; Ferrer S; Fiandor JM; Gamo FJ; Gargallo-Viola D; Derimanov G
Future Med Chem; 2012 Dec; 4(18):2311-23. PubMed ID: 23234553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]